drugset / Trial / NCT05094102
Intraoperative Evaluation of Axillary Lymphatics
Completed
9 enrolled
University of Wisconsin, Madison
National Cancer Institute (NCI) · collabNational Institutes of Health (NIH) · collabOnLume Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
This study will assess the feasibility of using the OnLume Imaging System for fluorescence-guided surgery along with indocyanine green (ICG) dye in the operating room for the axillary reverse mapping (ARM) procedure in women with breast cancer scheduled to have axillary dissection (AD) or sentinel lymph node (SLN) biopsy.
Timeline
- Start
- 2022-05-05
- Primary completion
- 2023-04-27
- Completion
- 2023-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | — | — |